Pharmaceutical Targeting of the Brain.

István A Krizbai; Ádám Nyúl-Tóth; Hans Christian Bauer; Attila E Farkas; Andreas Traweger; János Haskó; Hans Christian Bauer; Imola Wilhelm

Pharmaceutical Targeting of the Brain.

István A Krizbai, Ádám Nyúl-Tóth, Hans Christian Bauer (Co-author), Attila E Farkas, Andreas Traweger (Co-author), János Haskó, Hans Christian Bauer (Co-author), Imola Wilhelm

Institute of Tendon and Bone Regeneration

Research output: Contribution to journal › Original Article › peer-review

27 Citations (Web of Science)

Original language	English
Pages (from-to)	5442-5462
Journal	CURRENT PHARMACEUTICAL DESIGN
Volume	22
Issue number	35
Publication status	Published - 2016

Keywords

CENTRAL-NERVOUS-SYSTEM
SOLID LIPID NANOPARTICLES
CEREBRAL ENDOTHELIAL-CELLS
RABIES VIRUS GLYCOPROTEIN
DRUG-DELIVERY SYSTEM
POLY(LACTIC-CO-GLYCOLIC ACID) NANOPARTICLES
ANTITRANSFERRIN RECEPTOR ANTIBODY
GLUTATHIONE-COATED NANOPARTICLES
MESENCHYMAL STEM-CELLS
IN-VITRO MODELS

Cite this

Krizbai, I. A., Nyúl-Tóth, Á., Bauer, H. C., Farkas, A. E., Traweger, A., Haskó, J., Bauer, H. C., & Wilhelm, I. (2016). Pharmaceutical Targeting of the Brain. CURRENT PHARMACEUTICAL DESIGN , 22(35), 5442-5462.

Krizbai, István A ; Nyúl-Tóth, Ádám ; Bauer, Hans Christian et al. / Pharmaceutical Targeting of the Brain. In: CURRENT PHARMACEUTICAL DESIGN 2016 ; Vol. 22, No. 35. pp. 5442-5462.

@article{dc61c37883fe4ff19870a27e4ba5e4a4,

title = "Pharmaceutical Targeting of the Brain.",

keywords = "CENTRAL-NERVOUS-SYSTEM, SOLID LIPID NANOPARTICLES, CEREBRAL ENDOTHELIAL-CELLS, RABIES VIRUS GLYCOPROTEIN, DRUG-DELIVERY SYSTEM, POLY(LACTIC-CO-GLYCOLIC ACID) NANOPARTICLES, ANTITRANSFERRIN RECEPTOR ANTIBODY, GLUTATHIONE-COATED NANOPARTICLES, MESENCHYMAL STEM-CELLS, IN-VITRO MODELS",

author = "Krizbai, \{Istv{\'a}n A\} and {\'A}d{\'a}m Ny{\'u}l-T{\'o}th and Bauer, \{Hans Christian\} and Farkas, \{Attila E\} and Andreas Traweger and J{\'a}nos Hask{\'o} and Bauer, \{Hans Christian\} and Imola Wilhelm",

note = "Bauer HC, Traweger: Institute of Tendon and Bone Regeneration, Paracelsus Medical University - Spinal Cord Injury and Tissue Regeneration Center Salzburg, Strubergasse 21, 5020 Salzburg, Austria",

year = "2016",

language = "English",

volume = "22",

pages = "5442--5462",

journal = "CURRENT PHARMACEUTICAL DESIGN ",

issn = "1381-6128",

number = "35",

}

Krizbai, IA, Nyúl-Tóth, Á, Bauer, HC, Farkas, AE, Traweger, A, Haskó, J, Bauer, HC & Wilhelm, I 2016, 'Pharmaceutical Targeting of the Brain.', CURRENT PHARMACEUTICAL DESIGN , vol. 22, no. 35, pp. 5442-5462.

Pharmaceutical Targeting of the Brain. / Krizbai, István A; Nyúl-Tóth, Ádám; Bauer, Hans Christian (Co-author) et al.
In: CURRENT PHARMACEUTICAL DESIGN , Vol. 22, No. 35, 2016, p. 5442-5462.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Pharmaceutical Targeting of the Brain.

AU - Krizbai, István A

AU - Nyúl-Tóth, Ádám

AU - Bauer, Hans Christian

AU - Farkas, Attila E

AU - Traweger, Andreas

AU - Haskó, János

AU - Bauer, Hans Christian

AU - Wilhelm, Imola

N1 - Bauer HC, Traweger: Institute of Tendon and Bone Regeneration, Paracelsus Medical University - Spinal Cord Injury and Tissue Regeneration Center Salzburg, Strubergasse 21, 5020 Salzburg, Austria

PY - 2016

Y1 - 2016

KW - CENTRAL-NERVOUS-SYSTEM

KW - SOLID LIPID NANOPARTICLES

KW - CEREBRAL ENDOTHELIAL-CELLS

KW - RABIES VIRUS GLYCOPROTEIN

KW - DRUG-DELIVERY SYSTEM

KW - POLY(LACTIC-CO-GLYCOLIC ACID) NANOPARTICLES

KW - ANTITRANSFERRIN RECEPTOR ANTIBODY

KW - GLUTATHIONE-COATED NANOPARTICLES

KW - MESENCHYMAL STEM-CELLS

KW - IN-VITRO MODELS

M3 - Original Article

C2 - 27464716

SN - 1381-6128

VL - 22

SP - 5442

EP - 5462

JO - CURRENT PHARMACEUTICAL DESIGN

JF - CURRENT PHARMACEUTICAL DESIGN

IS - 35

ER -

Krizbai IA, Nyúl-Tóth Á, Bauer HC, Farkas AE, Traweger A, Haskó J et al. Pharmaceutical Targeting of the Brain. CURRENT PHARMACEUTICAL DESIGN . 2016;22(35):5442-5462.